1,4-dihydropyridine has been researched along with Carcinoma, Squamous Cell in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Akhtar, S; Ghosh, R; Kumar Mandal, T; Maiti, P; Manna, D; Mondal, S | 1 |
Huo, J; Li, L; Liu, W; Qin, T; Shi, X; Wang, C; Yang, D; Zhang, X; Zhang, Y; Zhou, K | 1 |
Curti, C; Garcia, CB; Goto, RN; Leopoldino, AM; Lopes, NP; Marín-Prida, J; Ochoa-Rodríguez, E; Pardo-Andreu, GL; Sobral, LM; Sousa, LO; Verdecia-Reyes, Y | 1 |
Ishibashi, T; Nishio, M; Yoshida, J | 1 |
4 other study(ies) available for 1,4-dihydropyridine and Carcinoma, Squamous Cell
Article | Year |
---|---|
Anticancer activity of a 1,4-dihydropyridine in DMBA-induced mouse skin tumor model.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Calcium Channel Blockers; Carcinogens; Carcinoma, Squamous Cell; Cell Proliferation; Dihydropyridines; Male; Mice; Organ Size; Skin Neoplasms; Tumor Cells, Cultured | 2020 |
Selective anticancer activity of the novel steroidal dihydropyridine spirooxindoles against human esophageal EC109 cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Dihydropyridines; Drug Resistance; Esophageal Neoplasms; G2 Phase Cell Cycle Checkpoints; Humans; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Small Molecule Libraries | 2017 |
Anti-cancer activity of a new dihydropyridine derivative, VdiE-2N, in head and neck squamous cell carcinoma.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dihydropyridines; Gene Expression Regulation, Neoplastic; Genes, myc; Head and Neck Neoplasms; Humans; Membrane Potential, Mitochondrial; Mice; Mitochondrial Size; Neoplasm Invasiveness; Neovascularization, Pathologic; Squamous Cell Carcinoma of Head and Neck; Xenograft Model Antitumor Assays | 2018 |
G1 cell cycle arrest by amlodipine, a dihydropyridine Ca2+ channel blocker, in human epidermoid carcinoma A431 cells.
Topics: Amlodipine; Calcium Channel Blockers; Carcinoma, Squamous Cell; Cell Cycle; Cell Cycle Proteins; Cyclin-Dependent Kinases; Dihydropyridines; G1 Phase; Humans; Nuclear Proteins; Phosphorylation; Repressor Proteins; Tumor Cells, Cultured | 2007 |